COO of Kamineni Hospitals Applauds Government Move to Ease Access to Critical Medicines
Dr. Gayatri Kamineni, Chief Operating Officer of Kamineni Hospitals, has welcomed the Union Budget 2026-27 announcement to exempt basic customs duty on 17 cancer drugs and medicines for seven additional rare diseases, describing it as a “highly progressive step” toward improving healthcare affordability in India.
New Delhi: Dr. Gayatri Kamineni, Chief Operating Officer of Kamineni Hospitals, has welcomed the Union Budget 2026-27 announcement to exempt basic customs duty on 17 cancer drugs and medicines for seven additional rare diseases, describing it as a “highly progressive step” toward improving healthcare affordability in India.
Dr. Kamineni emphasized that equitable access to advanced medical care is essential, and policy measures like this help strengthen the overall healthcare ecosystem. “We appreciate the government’s continued focus on patient-centric reforms and hope this move will provide tangible relief to thousands of patients across the country,” she said.
Follow for more details: munsifdaily.com
She noted that reducing import duties on critical medicines will make life-saving treatments more accessible and enable healthcare institutions to provide the most appropriate care without cost being a limiting factor.
“This decision represents a significant step toward improving treatment outcomes and ensuring that patients receive timely and effective medical intervention,” Dr. Kamineni added.
